| Financial Year |
March 31 2023 |
| Monetary Funds |
736,699,541.11 |
| Held-for-trading Financial Assets |
362,043,604.48 |
| Notes Receivable |
25,388,751.38 |
| Accounts Receivable |
459,461,481.16 |
| Advances to Suppliers |
27,696,667.56 |
| Other Receivables |
32,205,270.48 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
90,191,392.54 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
81,193,647.91 |
| Total Current Assets |
1,865,528,157.70 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
6,287,407.67 |
| Investment Properties |
-- |
| Fixed Assetes |
1,036,976,875.74 |
| Under-construction Projects |
693,877,195.09 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
219,059,457.00 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
-- |
| Deferred Income Tax Assets |
16,691,030.16 |
| Other Non-Current Assets |
3,848,539.41 |
| Sub-Total of Non-Current Assets |
1,996,572,607.80 |
| Total Assets |
3,862,100,765.50 |
| Short-Term Loans |
189,116,477.29 |
| Trading Financial liabilities |
-- |
| Notes Payable |
170,520,588.63 |
| Accounts Payable |
324,649,059.53 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
11,488,782.89 |
| Taxes Payable |
42,089,391.82 |
| Interest Payable |
-- |
| Dividend Payable |
19,826,065.98 |
| Other payables |
35,595,106.17 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
12,208,489.79 |
| Other Current Liabilities |
776,923.87 |
| Sub-Total of Current Liabilities |
795,035,128.58 |
| Long-term Loans |
-- |
| Bonds Payable |
685,313,719.71 |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
20,621,452.53 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
736,246,844.34 |
| Total Liabilities |
1,531,281,972.93 |
| Paid-In Capital(Or Share Stock) |
233,248,267.00 |
| Capital Surplus |
677,870,682.56 |
| Surplus Reserve |
96,422,673.50 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
1,189,502,384.03 |
| Minority Stockholder's Interest |
7,100,356.20 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
2,323,718,436.37 |
| Owner's Equity（Stockholder's Equity） |
2,330,818,792.57 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
3,862,100,765.50 |
